First Trust, one of the largest issuers of US ETFs, terminated TCW Group Inc. as the manager of four exchange-traded funds ...

Filgotinib, a Janus Kinase 1 inhibitor, remains well-tolerated for up to 8 years with consistent efficacy in patients with ...

In its effort to rival GSK’s shingles vaccine Shingrix, Curevo Vaccine has circled up $110 million and recruited two former ...

Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as ...

EverCommerce (NASDAQ:EVCM – Free Report) had its price target reduced by Oppenheimer from $13.00 to $12.00 in a research note issued to investors on Friday,Benzinga reports. They currently have an ...

Povorcitinib is an oral Janus kinase 1 selective inhibitor that works to reduce the overactive inflammatory signaling pathway seen in HS.

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.

EverCommerce (NASDAQ:EVCM – Free Report) had its price objective lowered by Jefferies Financial Group from $12.00 to $10.00 ...

To list the 12 Best Quality Stocks to Invest in Now, we sifted through the holdings of iShares MSCI USA Quality Factor ETF.

Twice-daily application of ruxolitinib cream demonstrated an ability to reduce itching and blistering in prurigo nodularis, a ...